Standard BioTools Market Cap 2010-2024 | LAB
Standard BioTools market cap history and chart from 2010 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Standard BioTools market cap as of July 04, 2024 is $0.68B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.682B | $0.106B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $35.257B | 19.36 |
| Tempus AI (TEM) | United States | $5.669B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.401B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.980B | 0.00 |
| Axonics (AXNX) | United States | $3.445B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $3.202B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.010B | 0.00 |
| Azenta (AZTA) | United States | $2.800B | 157.42 |
| Enovis (ENOV) | United States | $2.438B | 18.07 |
| 10x Genomics (TXG) | United States | $2.234B | 0.00 |
| Privia Health (PRVA) | United States | $2.022B | 113.00 |
| Schrodinger (SDGR) | United States | $1.461B | 0.00 |
| Omnicell (OMCL) | United States | $1.229B | 42.48 |
| Phreesia (PHR) | United States | $1.177B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.631B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.621B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.596B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.365B | 0.00 |
| Talkspace (TALK) | United States | $0.365B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.305B | 0.00 |
| Pulmonx (LUNG) | United States | $0.245B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.209B | 0.00 |
| Outset Medical (OM) | United States | $0.199B | 0.00 |
| TruBridge (TBRG) | United States | $0.168B | 9.02 |
| P3 Health Partners (PIII) | United States | $0.157B | 0.00 |
| American Well (AMWL) | United States | $0.089B | 0.00 |
| 111 (YI) | China | $0.088B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.080B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.075B | 0.00 |
| HeartBeam (BEAT) | United States | $0.071B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.057B | 0.00 |
| Augmedix (AUGX) | United States | $0.049B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.048B | 0.00 |
| Zepp Health (ZEPP) | China | $0.039B | 0.00 |
| CareCloud (CCLD) | United States | $0.032B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.031B | 0.00 |
| Movano (MOVE) | United States | $0.031B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Syra Health (SYRA) | United States | $0.008B | 0.00 |
| Biotricity (BTCY) | United States | $0.007B | 0.00 |
| Transgenomic (PRPO) | United States | $0.007B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |